- Home
- MLM vs TAK Comparison
MLM vs TAK Comparison
Compare MLM & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLM
- TAK
- Stock Information
- Founded
- MLM 1993
- TAK 1781
- Country
- MLM United States
- TAK Japan
- Employees
- MLM N/A
- TAK N/A
- Industry
- MLM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- MLM Industrials
- TAK Health Care
- Exchange
- MLM Nasdaq
- TAK Nasdaq
- Market Cap
- MLM 34.0B
- TAK 45.8B
- IPO Year
- MLM 1994
- TAK N/A
- Fundamental
- Price
- MLM $558.75
- TAK $15.44
- Analyst Decision
- MLM Strong Buy
- TAK
- Analyst Count
- MLM 13
- TAK 0
- Target Price
- MLM $602.38
- TAK N/A
- AVG Volume (30 Days)
- MLM 394.8K
- TAK 2.1M
- Earning Date
- MLM 08-07-2025
- TAK 07-30-2025
- Dividend Yield
- MLM 0.57%
- TAK 3.52%
- EPS Growth
- MLM N/A
- TAK N/A
- EPS
- MLM 17.38
- TAK 0.45
- Revenue
- MLM $6,638,000,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- MLM $9.10
- TAK $1.01
- Revenue Next Year
- MLM $7.60
- TAK $1.04
- P/E Ratio
- MLM $32.14
- TAK $66.85
- Revenue Growth
- MLM N/A
- TAK 7.45
- 52 Week Low
- MLM $441.95
- TAK $12.80
- 52 Week High
- MLM $633.23
- TAK $15.53
- Technical
- Relative Strength Index (RSI)
- MLM 58.53
- TAK 61.77
- Support Level
- MLM $540.41
- TAK $14.90
- Resistance Level
- MLM $555.44
- TAK $15.53
- Average True Range (ATR)
- MLM 10.86
- TAK 0.15
- MACD
- MLM 0.68
- TAK 0.04
- Stochastic Oscillator
- MLM 92.59
- TAK 90.21
About MLM Martin Marietta Materials Inc.
Martin Marietta Materials is one of the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). In 2024, Martin Marietta sold 191 million tons of aggregates. Martin Marietta's most important markets include Texas, Colorado, North Carolina, Georgia, and Florida, accounting for most of its sales. The company also produces cement in Texas and uses its aggregates in its asphalt and ready-mixed concrete businesses. Martin's magnesia specialties business produces magnesia-based chemical products and dolomitic lime.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.